Kirstine Skov Benthien1,2, Mie Nordly3,4, Katja Videbæk4, Geana Paula Kurita3,5, Hans von der Maase3,4, Helle Timm6, Mette Kildevæld Simonsen7, Christoffer Johansen3,8, Per Sjøgren3,4. 1. Department of Oncology, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark. kirstine.skov.benthien@regionh.dk. 2. Faculty of Health and Medical Sciences, Copenhagen University, Blegdamsvej 3B, 2000, Copenhagen, Denmark. kirstine.skov.benthien@regionh.dk. 3. Department of Oncology, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark. 4. Faculty of Health and Medical Sciences, Copenhagen University, Blegdamsvej 3B, 2000, Copenhagen, Denmark. 5. Multidisciplinary Pain Centre, Department of Neuroanaesthesiology, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark. 6. Knowledge Centre for Rehabilitation and Palliative Care, University of Southern Denmark, Oester Farimagsgade 5A, 1353, Copenhagen, Denmark. 7. Finsen Centre, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark. 8. Unit of Survivorship Research, The Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.
Abstract
PURPOSE: The purposes of the present study were to classify the palliative care population (PCP) in a comprehensive cancer centre by using information on antineoplastic treatment options and to analyse associations between socio-demographic factors, cancer diagnoses, treatment characteristics and receiving specialist palliative care (SPC). METHODS: This is a cross-sectional screening study of patients with cancer in the Department of Oncology, Rigshospitalet, Copenhagen University Hospital for 6 months. Patients were assessed to be included in the DOMUS study: a randomised controlled trial of accelerated transition to SPC at home (NCT01885637). The PCP was classified as patients with incurable cancer and limited or no antineoplastic treatment options. Patients with performance status 2-4 were further classified as the essential palliative care population (EPCP). RESULTS: During the study period, 3717 patients with cancer were assessed. The PCP comprised 513 patients yielding a prevalence of 14 %. The EPCP comprised 256 patients (7 %). The EPCP was older, more likely inpatients, had a higher comorbidity burden and 38 % received SPC. Women, patients without caregivers and patients with breast cancer were more likely to receive SPC. CONCLUSIONS: By using objective criteria from clinical data and systematic screening, the observed prevalence of the PCP of 14 % may be generalisable to comprehensive cancer centres with similar composition of cancer diagnoses.
RCT Entities:
PURPOSE: The purposes of the present study were to classify the palliative care population (PCP) in a comprehensive cancer centre by using information on antineoplastic treatment options and to analyse associations between socio-demographic factors, cancer diagnoses, treatment characteristics and receiving specialist palliative care (SPC). METHODS: This is a cross-sectional screening study of patients with cancer in the Department of Oncology, Rigshospitalet, Copenhagen University Hospital for 6 months. Patients were assessed to be included in the DOMUS study: a randomised controlled trial of accelerated transition to SPC at home (NCT01885637). The PCP was classified as patients with incurable cancer and limited or no antineoplastic treatment options. Patients with performance status 2-4 were further classified as the essential palliative care population (EPCP). RESULTS: During the study period, 3717 patients with cancer were assessed. The PCP comprised 513 patients yielding a prevalence of 14 %. The EPCP comprised 256 patients (7 %). The EPCP was older, more likely inpatients, had a higher comorbidity burden and 38 % received SPC. Women, patients without caregivers and patients with breast cancer were more likely to receive SPC. CONCLUSIONS: By using objective criteria from clinical data and systematic screening, the observed prevalence of the PCP of 14 % may be generalisable to comprehensive cancer centres with similar composition of cancer diagnoses.
Entities:
Keywords:
Demography; Neoplasm; Palliative care; Population characteristics
Authors: Wouter Van Mechelen; Bert Aertgeerts; Karolien De Ceulaer; Bregje Thoonsen; Mieke Vermandere; Franca Warmenhoven; Eric Van Rijswijk; Jan De Lepeleire Journal: Palliat Med Date: 2012-02-06 Impact factor: 4.762
Authors: Jennifer Philip; Anna Collins; Caroline A Brand; Michelle Gold; Gaye Moore; Vijaya Sundararajan; Michael A Murphy; Carrie Lethborg Journal: Palliat Support Care Date: 2013-10-21
Authors: Bridget Gwilliam; Vaughan Keeley; Chris Todd; Matthew Gittins; Chris Roberts; Laura Kelly; Stephen Barclay; Patrick C Stone Journal: BMJ Date: 2011-08-25
Authors: Mie Nordly; Kirstine Skov Benthien; Hans Von Der Maase; Christoffer Johansen; Marie Kruse; Helle Timm; Eva Soelberg Vadstrup; Geana Paula Kurita; Annika Berglind von Heymann-Horan; Per Sjøgren Journal: BMC Palliat Care Date: 2014-09-09 Impact factor: 3.234
Authors: Mariëtte N Verkissen; Aline De Vleminck; Mogens Groenvold; Lea J Jabbarian; Francesco Bulli; Wilfried Cools; Johannes J M van Delden; Urška Lunder; Guido Miccinesi; Sheila A Payne; Kristian Pollock; Judith A C Rietjens; Luc Deliens Journal: Support Care Cancer Date: 2021-03-19 Impact factor: 3.603